HC Wainwright & Co. Maintains Buy on Viking Therapeutics, Raises Price Target to $102
Viking Therapeutics Analyst Ratings
Daily short sale tracking: Viking Therapeutics's short volume increased by 3 million, with a short sale ratio of 14%
Viking Therapeutics(VKTX.US) ranked top of the list had the largest change in short volume (3.8 million shares), and the short volume ratio of Enbridge(ENB.US) reached 58.29%. See more about the top 10 list of short selling volume changes in the latest trading day of the US stock market.
A Quick Look at Today's Ratings for Viking Therapeutics(VKTX.US), With a Forecast Between $95 to $118
Social Buzz: Wallstreetbets Stocks Advance Premarket Tuesday; Palantir Technologies, Hims & Hers Health to Open Higher
Viking Therapeutics (VKTX.US) weight loss drug emerging unexpectedly, challenging the traditional leaders in the field.
The data released earlier on Monday by viking therapeutics on the weight-loss drug VK2735 indicates that novo-nordisk a/s and eli lilly and co, currently dominating the obesity drug market, may face fierce competition in the future.